Showing results (131-140 of 341) with videos related to

Sort By:
Pageof 35
Journal of the American College of Cardiology|July 2, 2013
Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure)Romain Eschalier, John J V McMurray, Karl Swedberg, et al.
European Journal of Heart Failure|May 22, 2012
Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)David Preiss, Dirk J van Veldhuisen, Naveed Sattar, et al.
Journal of the American College of Cardiology|March 19, 2021
Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced TrialMilton Packer, Stefan D Anker, Javed Butler, et al.
European Journal of Heart Failure|May 30, 2021
Concentration-dependent clinical and prognostic importance of high-sensitivity cardiac troponin T in heart failure and a reduced ejection fraction and the influence of empagliflozin: the EMPEROR-Reduced trialMilton Packer, James L Januzzi, Joao Pedro Ferreira, et al.
European Heart Journal|July 5, 2022
Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trialWolfram Doehner, Stefan D Anker, Javed Butler, et al.
European Journal of Heart Failure|January 22, 2024
Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-PreservedTripti Rastogi, João Pedro Ferreira, Javed Butler, et al.
European Journal of Heart Failure|January 24, 2014
Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-PreservedJennifer K Rogers, Stuart J Pocock, John J V McMurray, et al.
Diabetes Care|September 11, 2014
Rationale and design of the Vitamin D and Type 2 Diabetes (D2d) study: a diabetes prevention trialAnastassios G Pittas, Bess Dawson-Hughes, Patricia R Sheehan, et al.
European Heart Journal|October 13, 2005
Predictors of mortality and morbidity in patients with chronic heart failureStuart J Pocock, Duolao Wang, Marc A Pfeffer, et al.
European Heart Journal|August 26, 2022
Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programmeFaiez Zannad, João Pedro Ferreira, Javed Butler, et al.
Pageof 35